Related by context. All words. (Click for frequent words.) 75 lipid lowering therapy 74 statins 73 statin 73 antiplatelet therapy 69 clopidogrel 69 aspirin therapy 69 dose aspirin 68 rosuvastatin 68 antihypertensive therapy 68 warfarin therapy 68 beta blocker therapy 67 candesartan 67 pioglitazone 67 vitamin D supplementation 67 dual antiplatelet therapy 66 antihypertensive medications 66 cardiovascular mortality 66 dose statin therapy 65 metformin 65 lipid lowering drugs 65 allopurinol 65 inhaled corticosteroids 65 calcium supplementation 65 β blockers 65 antihypertensive drugs 65 lowering LDL cholesterol 65 cardiovascular morbidity 64 LDL C 64 HbA1c levels 64 valsartan 64 ACE inhibitors 64 anticoagulation 64 ivabradine 64 hypertensive patients 64 bisphosphonate therapy 64 rosiglitazone 64 LDL lowering 64 NATRECOR R 64 inhaled steroids 63 lipid lowering 63 antithrombotic therapy 63 cholesterol lowering medication 63 statin drugs 63 warfarin 63 ramipril 63 adalimumab 63 glucose lowering 63 LDL cholesterol levels 63 unfractionated heparin 63 lipid lowering medications 62 eptifibatide 62 acute coronary syndrome 62 thrombolytic therapy 62 elevated CRP 62 intensive statin therapy 62 elevated LDL cholesterol 62 randomized clinical trials 62 cholesterol lowering drugs 62 perindopril 62 ATACAND 62 coronary artery disease 62 myocardial infarction 62 statin medications 62 NSAID 62 adjuvant chemotherapy 62 Lp PLA2 62 randomized trials 62 homocysteine levels 62 tirofiban 62 NSAIDs 62 glycemic control 62 lipid levels 62 testosterone supplementation 61 dose clopidogrel 61 ticagrelor 61 platelet inhibition 61 peginterferon 61 anticoagulant therapy 61 AIM HIGH 61 ACE inhibitor 61 atherothrombotic events 61 sunitinib 61 TZDs 61 fondaparinux 61 carotid endarterectomy 61 atorvastatin 61 antiplatelet agents 61 DAPT 61 thiazide diuretics 61 hsCRP 61 carvedilol 61 thromboembolic 61 antihypertensive agents 61 platelet reactivity 61 ALLHAT 61 subclinical hypothyroidism 61 venous thromboembolism 61 triglyceride levels 61 HAART 61 LDL cholesterol lowering 61 anastrozole 61 angiotensin receptor blockers 61 coronary artery calcium 60 antidepressant therapy 60 beta blockers 60 antiretroviral therapy 60 antithrombotic 60 tamoxifen therapy 60 coronary disease 60 cardiovascular disease 60 dose atorvastatin 60 telmisartan 60 menopausal hormone therapy 60 atherosclerotic disease 60 fluvastatin 60 tamoxifen 60 antihypertensive medication 60 virological failure 60 resistant hypertension 60 postoperative AF 60 thrombotic events 60 recurrent VTE 60 acute coronary syndromes 60 ACTOS 60 thromboembolic events 60 COPAXONE R 60 hemoglobin A1c levels 60 stable angina 60 thiazolidinediones 60 postoperative mortality 60 left ventricular dysfunction 60 adjuvant therapy 60 abacavir 60 ezetimibe simvastatin 59 androgen deprivation 59 tocilizumab 59 hydroxychloroquine 59 paclitaxel eluting stents 59 imatinib 59 paricalcitol 59 glitazones 59 VTE 59 thiazolidinedione 59 coronary revascularization 59 insulin glargine 59 eplerenone 59 GnRH agonists 59 losartan 59 myocardial infarction MI 59 bezafibrate 59 chemoradiotherapy 59 dyslipidaemia 59 darapladib 59 ezetimibe 59 severe psoriasis 59 microalbuminuria 59 coronary heart 59 intensive lipid lowering 59 bevacizumab 59 antihypertensive 59 virologic failure 59 observational studies 59 simvastatin 59 mycophenolate mofetil 59 PPIs 59 cilostazol 59 comorbidities 59 thromboprophylaxis 59 microvascular complications 59 anticoagulation therapy 59 preoperative chemotherapy 59 subgroup analyzes 59 carotid IMT 59 dronedarone 59 hormone therapy 59 KIF6 carriers 59 ischemic stroke 59 vicriviroc 59 eprotirome 59 NSTE ACS 59 lowering homocysteine 59 nonfatal MI 59 hypercholesterolemia 59 hormonal therapy 59 enoxaparin 59 clopidogrel Plavix 58 spironolactone 58 salmeterol 58 antidiabetic drugs 58 antioxidant supplementation 58 rivaroxaban 58 estrogen therapy 58 pregabalin 58 postmenopausal women 58 antiarrhythmic drug 58 vertebral fracture 58 bevacizumab Avastin 58 angiotensin receptor blocker ARB 58 aldosterone antagonist 58 pre menopausal 58 glycated hemoglobin levels 58 macrovascular disease 58 antidepressant medications 58 hs CRP 58 serum uric acid 58 estrogen progestin therapy 58 revascularization procedures 58 tiotropium 58 glycemia 58 ICD therapy 58 subclinical atherosclerosis 58 bosentan 58 cardiac toxicity 58 VADT 58 COREG 58 LV dysfunction 58 calcium supplements 58 prescribe statins 58 A1c levels 58 prescribed statins 58 postmenopausal hormone therapy 58 adenoma recurrence 58 NATRECOR ® 58 reinfarction 58 omalizumab 58 Subgroup analyzes 58 carotid stenting 58 dyslipidemia 58 HDL C 58 antiplatelet drugs 58 aspirin clopidogrel 58 BYSTOLIC 58 colorectal neoplasia 58 zoledronic acid 58 patients undergoing CABG 58 HbA 1c 58 nonrandomized 58 spontaneous preterm delivery 58 venous thrombosis 58 TZD 58 lipid lowering agents 58 renal dysfunction 58 cholesterol lowering statins 58 dabigatran 58 randomized controlled trials 58 ICD implantation 58 aspirin regimen 58 olmesartan 58 elevated triglyceride levels 58 Combination therapy 58 polyp recurrence 58 rFVIIa 58 corticosteroids 58 abciximab 58 liver transplant recipients 58 rosuvastatin #mg 58 folate intake 58 MADIT II 57 vitamin D supplements 57 hsCRP levels 57 DMARD 57 inhaled steroid 57 beta blocker 57 Atacand 57 APTIVUS r 57 dietary modification 57 corticosteroid therapy 57 temsirolimus 57 rosuvastatin Crestor 57 selenium supplementation 57 drug eluting stents 57 aspirin 57 selenium supplements 57 azacitidine 57 atherosclerosis 57 concomitant medications 57 atorvastatin Lipitor 57 asymptomatic carotid stenosis 57 tamsulosin 57 randomized clinical 57 sirolimus 57 Hydroxyurea 57 aliskiren 57 oral bisphosphonates 57 proteinuria 57 poor metabolizers 57 coxibs 57 mixed hyperlipidemia 57 cardiovascular hospitalization 57 SCD HeFT 57 antiplatelet 57 androgen deprivation therapy 57 repeat revascularization 57 levosimendan 57 beta carotene supplements 57 LDL cholesterol 57 tolvaptan 57 infliximab 57 NPH insulin 57 neoadjuvant chemotherapy 57 PREZISTA r 57 hypertension 57 thromboembolism 57 multivessel disease 57 CVD mortality 57 stenting 57 exemestane 57 chemoradiation 57 myocardial infarctions 57 ACCORD Lipid 57 muraglitazar 57 angiotensin receptor blockers ARBs 57 sustained virologic response 57 oral anticoagulants 57 cardiovascular 57 lipid lowering therapies 57 benazepril 57 familial hypercholesterolemia 57 symptomatic VTE 57 RE LY 57 nesiritide 57 ADHF 57 NAFLD 57 A1C levels 57 STEMI patients 57 metformin sulfonylurea 57 chemoprevention 57 periprocedural MI 57 placebo controlled trials 57 fibrate 57 Welchol 57 risk stratification 57 comorbid conditions 57 aldosterone antagonists 57 antioxidant supplements 57 aromatase inhibitor 57 cirrhotic patients 57 olaparib 57 alteplase 57 BENICAR HCT 57 candesartan cilexetil 57 serum calcium levels 57 oral antidiabetic drugs 57 ACE inhibitor ramipril 57 CYPHER ® Stent 57 systolic hypertension 57 vascular disease 56 disease progression 56 subclinical hyperthyroidism 56 cerebral microbleeds 56 APPRAISE 56 magnesium intake 56 iniparib 56 HAART regimens 56 mg dL 56 angiotensin converting enzyme inhibitor 56 Hb A1C 56 ischemic cardiomyopathy 56 T2DM 56 antidiabetic therapy 56 celecoxib 56 methotrexate 56 noncardiac surgery 56 primary hypercholesterolemia 56 NSAID therapy 56 angiotensin converting enzyme inhibitors 56 teriflunomide 56 BARI 2D 56 LMWH 56 upper gastrointestinal bleeding 56 cART 56 adiponectin levels 56 TACE 56 antithrombotic therapies 56 HDL cholesterol 56 serum vitamin D 56 hydroxyvitamin D levels 56 lupus nephritis 56 bisphosphonate 56 oral antidiabetic medication 56 serum creatinine levels 56 antiplatelet agent 56 sUA 56 lamotrigine 56 angiotensin converting enzyme ACE 56 PSADT 56 HYVET 56 treatment regimens 56 CYPHER R Stent 56 dose colchicine 56 immunosuppressive agents 56 fat diet 56 VTE prophylaxis 56 atherogenic dyslipidemia 56 vandetanib 56 androgen deficiency 56 irbesartan 56 intravenous bisphosphonates 56 endarterectomy 56 fasting glucose levels 56 nonvertebral fractures 56 interferon therapy 56 LVEF 56 serum calcium 56 abatacept 56 paroxysmal AF 56 GP IIb IIIa inhibitors 56 antibiotic prophylaxis 56 insulin detemir 56 bisphosphonates 56 prescribing statins 56 phosphate binders 56 antiepileptic drugs 56 baseline HbA1c 56 sorafenib 56 loop diuretics 56 anti TNF 56 tricyclic antidepressants 56 pegylated interferon alfa 2b 56 serum cholesterol 56 Statin therapy 56 thrombolytic agents 56 dutasteride 56 antihypertensives 56 idraparinux 56 nonadherence 56 tibolone 56 pravastatin Pravachol 56 reperfusion therapy 56 folate supplementation 56 hyperkalemia 56 cTnT levels 56 vitamin E 56 FASLODEX 56 fenofibrate 56 ximelagatran 56 pravastatin 56 ruboxistaurin 56 Dabigatran 56 Rosuvastatin 56 donepezil 56 antiplatelet therapies 56 fasting triglyceride levels 56 HIV HCV coinfected 56 trials RCTs 56 NRTIs 56 CMV infection 56 immunosuppression 56 antimicrobial prophylaxis 56 cardio protective 56 sirolimus eluting stents 56 glucocorticoids 56 TORISEL 56 unstable angina 56 myocardial infarction stroke 56 typical antipsychotics 56 carotid artery stenting 56 cholesterol lowering statin 56 venous thromboembolic events 56 carotid atherosclerosis 56 Candesartan 56 unstable angina UA 56 periprocedural 56 thiazide diuretic 56 pioglitazone Actos 56 d4T 56 simvastatin ezetimibe 56 hemoglobin A1c HbA1c 56 valproate 56 randomized controlled clinical trials 56 CYPHER Stent 56 DASH diet 56 SYMBICORT 55 clozapine 55 atherothrombotic disease 55 conventional antipsychotics 55 decitabine 55 acute myocardial infarction AMI 55 LABAs 55 prospectively defined 55 chlorthalidone 55 acting beta agonists 55 diabetes mellitus 55 tHcy 55 dacarbazine 55 cardiovascular disease CVD 55 carotid stenosis 55 STRIDE PD 55 antiarrhythmic drugs 55 UKPDS 55 cerebrovascular events 55 lipoprotein levels 55 fibrates 55 ExTRACT TIMI 55 APTIVUS 55 aprotinin 55 carboplatin paclitaxel 55 postmenopausal breast cancer 55 screening mammography 55 premenopausal 55 amlodipine 55 severe aortic stenosis 55 oral anticoagulation 55 Framingham Offspring Study 55 cetuximab 55 Doxil ® 55 colesevelam HCl 55 breast cancer recurrence 55 antithrombotic agents 55 contralateral breast cancer 55 letrozole 55 coronary intervention 55 eGFR 55 coronary interventions 55 elevated triglycerides 55 vertebral fractures 55 C reactive protein 55 quetiapine 55 sulfonylurea 55 acid suppressing 55 azathioprine 55 revascularization 55 standard chemotherapy regimen 55 MULTAQ 55 anticoagulants 55 coronary angiography 55 cytotoxic chemotherapy 55 beta blocker atenolol 55 STEMI 55 metabolic syndrome 55 inhaled anticholinergics 55 SPARCL 55 atypical antipsychotics 55 postmenopausal 55 serum phosphorus 55 hyperglycaemia 55 albuminuria 55 premenopausal women 55 erlotinib 55 screening colonoscopy 55 ticlopidine 55 thrombolysis 55 RCTs 55 trastuzumab 55 teriparatide 55 CETP inhibition 55 Adjuvant chemotherapy 55 AZOR 55 ARIXTRA 55 hyperphosphatemia 55 canakinumab 55 clinically meaningful 55 gemcitabine Gemzar 55 hypercholesterolaemia 55 oophorectomy 55 neoadjuvant 55 Cardiovascular Risk 55 hypertensive 55 sulphonylurea 55 modifiable risk 55 asymptomatic 55 systemic corticosteroids 55 folic acid supplementation 55 elevated homocysteine 55 risedronate 55 imatinib therapy 55 surrogate endpoint 55 immunosuppressant therapy 55 adjuvant endocrine therapy 55 renal impairment 55 hypertensives 55 coronary blockages 55 systolic blood pressure 55 antioxidant vitamin supplements 55 cystatin C 55 Fonarow 55 pharmacologic treatments 55 antipsychotics 55 Vitamin D supplementation 55 nonfasting triglycerides 55 HSCT 55 everolimus eluting stents 55 methotrexate therapy 55 anti leukemic 55 dose cytarabine 55 vitamin D intake 55 DCCT 55 BENICAR 55 prostate cancer CRPC 55 calcium channel 55 prehypertension 55 virologic response 55 montelukast 55 apixaban 55 Valsartan 55 nonfasting triglyceride levels 55 glitazone 55 elective PCI 55 PSA screening 55 clopidogrel pretreatment 55 aripiprazole 55 cholinesterase inhibitors 55 sertraline 55 androgen suppression 55 diastolic heart 55 revascularisation 55 VIRAMUNE 55 decompensated heart failure 55 LVSD 55 chemotherapy regimen 55 sustained virological response 55 indapamide 55 AVODART 55 ACEIs 55 rimonabant #mg 55 ARCOXIA 55 carotid intima media 55 Sorafenib 55 Revlimid lenalidomide 55 hormone therapy estrogen 55 H. pylori eradication 55 atherosclerotic 55 metastatic RCC 54 revascularizations 54 RE LY ® 54 nephrotoxicity 54 strontium ranelate 54 pharmacotherapy 54 AZILECT 54 atazanavir 54 contrast induced nephropathy 54 Clopidogrel 54 Rasilez Tekturna 54 raltegravir 54 UA NSTEMI 54 fat diets 54 cinacalcet 54 renal function 54 HoFH 54 Pioglitazone 54 drug eluting stent implantation 54 prednisone prednisolone 54 bivalirudin 54 anakinra 54 anticlotting drugs 54 TNF antagonist 54 carotid plaque 54 antidepressant medication 54 myocardial ischemia 54 5-FU/LV 54 cholinesterase inhibitor 54 olanzapine 54 androgen therapy 54 antiplatelet medications 54 antiretroviral regimen 54 troponin T 54 urate levels 54 colorectal liver metastases 54 colorectal cancer 54 rituximab 54 CYP#C# [001] 54 antiplatelet medication 54 impaired fasting glucose 54 undergoing coronary angiography 54 colorectal adenoma 54 ST elevation myocardial 54 glatiramer acetate 54 sunitinib malate 54 riociguat 54 uncontrolled asthma 54 pCR 54 monotherapy 54 thrombotic complications 54 cardiotoxicity 54 prasugrel 54 chemotherapy regimens 54 preserved ejection fraction 54 prophylactic anticoagulation 54 serum urate 54 COPD exacerbations 54 Telmisartan 54 HMG CoA reductase inhibitors 54 meta analysis 54 APTIVUS ritonavir 54 Kaplan Meier analysis 54 macrovascular 54 myocardial infarctions MIs 54 ischemic complications 54 sorafenib Nexavar 54 amiodarone 54 cabazitaxel 54 systolic BP 54 stratify patients 54 co morbidities 54 ARB telmisartan 54 proliferative diabetic retinopathy 54 nonfatal stroke 54 cholesterol lowering medications 54 entecavir 54 lacosamide 54 statins cholesterol lowering 54 CMV disease 54 lipid lowering medication 54 recurrent stroke 54 romiplostim 54 ACTIVE W 54 anacetrapib 54 AEGR 54 TNF inhibitors 54 ACUITY trial 54 thrombophilia 54 gefitinib 54 T1DM 54 HbA1c 54 tofacitinib 54 osteoporotic fractures 54 fulvestrant 54 rosiglitazone Avandia 54 ischemic strokes 54 nondiabetic patients 54 A1C 54 IV bisphosphonates 54 prescribed statin 54 tecarfarin 54 noninferiority 54 metastatic renal cell carcinoma 54 glycated hemoglobin HbA1c 54 postoperative atrial fibrillation 54 PRADAXA 54 PSA velocity 54 glucocorticoid therapy 54 acute ischemic stroke 54 Statin drugs 54 sevelamer 54 advanced adenomas 54 NNRTI 54 gallstone disease 54 etanercept 54 Femara letrozole 54 dosage regimens 54 ARIMIDEX 54 proton pump inhibitor 54 selective COX 2 54 pimecrolimus 54 BRCA mutations 54 Celecoxib 54 ICD implants 54 uric acid levels 54 pyridostigmine 54 Atacand ® 54 meta analyzes 54 coronary calcification 54 fragility fracture 54 AVANDIA 54 gemcitabine 54 nab paclitaxel 54 serum phosphorous 54 anthracyclines 54 HbA 1c levels 54 microvascular disease 54 fosamprenavir 54 perioperative mortality 54 HF ACTION 54 hemoglobin A1c 54 hydroxyurea 54 otamixaban 54 lumiracoxib 54 HORIZONS AMI trial 54 antiretroviral therapy ART 54 verapamil 54 drugs NSAIDs 54 selenium intake 54 ISENTRESS 54 proton pump inhibitors 54 adjuvant therapies 54 revascularization procedure 54 perioperatively 54 pertuzumab 54 atypical antipsychotic medications 54 acute STEMI 54 ONTARGET 54 Mylotarg 54 Abbott Trilipix 54 catheter angiography 54 vitamin D insufficiency 54 atheroma volume 54 antiviral therapy 54 dietary sodium 54 Stop Hypertension diet 54 percutaneous coronary intervention 54 virological response 54 KOMBIGLYZE XR 54 safinamide 54 Fibrates 54 beta carotene supplementation 54 prospective randomized 54 chlorambucil 54 thyroxine 54 uncontrolled hypertension 54 hyperglycemia 54 MERLIN TIMI 54 silent ischemia 53 severe hypoglycemia 53 rofecoxib 53 vasomotor symptoms 53 atrial fibrillation 53 acute coronary 53 KRAS status 53 CRESTOR 53 left ventricular hypertrophy 53 newer antipsychotics 53 inflammatory biomarkers 53 coronary artery calcification 53 supplementation 53 SSRIs 53 atrial fibrillation AF 53 recurrent venous thromboembolism 53 stent implantation 53 deferiprone 53 angiotensin II receptor blocker 53 macrovascular events 53 lomitapide 53 thromboembolic complications 53 docetaxel chemotherapy 53 Celebrex celecoxib 53 urate lowering therapy 53 CLA supplementation 53 mg dose 53 levodopa therapy 53 relapsing remitting multiple sclerosis 53 LEXIVA 53 Aliskiren 53 antiepileptic drug 53 pharmacologic intervention 53 fatal myocardial infarction 53 statin simvastatin 53 ALND 53 HAART regimen 53 severe renal impairment 53 myopathy rhabdomyolysis 53 NNRTIs 53 CARE HF 53 atherothrombosis 53 Plavix clopidogrel 53 asthma exacerbations 53 moderate renal impairment 53 atherosclerotic vascular disease 53 insulin sensitizers 53 tissue plasminogen activator tPA 53 TREDAPTIVE 53 plus progestin 53 fat vegan diet 53 definite stent thrombosis 53 metformin monotherapy 53 comorbidity 53 antigen PSA 53 hour bronchodilation 53 citalopram Celexa 53 FOLFOX4 53 glycoprotein IIb IIIa inhibitors 53 DMARD therapy 53 folate 53 DMARDs 53 abiraterone acetate 53 anticonvulsant drugs 53 peginterferon alfa 2a 53 #mg dose [003] 53 gout flares 53 Events MACE 53 abacavir lamivudine 53 noncardiovascular mortality 53 glycemic diet 53 oral corticosteroids 53 citalopram 53 PASI scores 53 diagnosed multiple myeloma 53 PegIFN RBV 53 bendamustine 53 mRCC 53 glargine 53 normotensive 53 recurrent ischemic 53 aromatase inhibitor therapy 53 inhaled corticosteroid therapy 53 paroxetine Paxil 53 alendronate 53 intima media thickness 53 esomeprazole 53 #mg/dL [001] 53 Lp PLA 2 53 Dasatinib 53 EBRT 53 pegylated interferon 53 heavily pretreated 53 Crestor rosuvastatin 53 biologic therapy 53 risperidone Risperdal 53 nonfatal myocardial infarction 53 lipid abnormalities 53 PROactive study 53 stratifying patients 53 recurrent ischemia 53 prostate cancer CaP 53 cisplatin chemotherapy 53 bronchial thermoplasty 53 alpha blocker 53 postoperative radiotherapy 53 nonvertebral fracture 53 clinically localized prostate 53 cardiovascular hospitalizations 53 Multaq R 53 transferrin saturation 53 adjuvant radiation 53 viral suppression 53 kidney transplant recipients 53 hypercalcemia 53 lipoprotein 53 Cholesterol Levels SPARCL 53 Abciximab 53 visilizumab 53 ibandronate 53 CABG 53 arterial stiffness 53 antipsychotic medications 53 neoadjuvant treatment 53 FROVA 53 ziprasidone Geodon 53 NYHA Class II 53 sudden cardiac death 53 antithrombotics 53 multivitamin supplements 53 adefovir 53 TRITON TIMI 53 hypercholesterolemic patients 53 biochemical recurrence 53 eltrombopag 53 ACTOplus met 53 Intervention Effectiveness 53 infusional 5-FU/LV 53 OADs 53 FFR guided treatment 53 Celecoxib APC trial 53 interferon ribavirin 53 vildagliptin 53 non valvular atrial 53 sulphonylureas 53 thiazides 53 infarct size 53 tumor recurrence 53 anti arrhythmic drug 53 Statins 53 pioglitazone HCl 53 tipranavir 53 triptans 53 ribavirin therapy 53 grade gliomas 53 antidiabetic agents 53 ABCB1 53 uric acid lowering 53 EFFEXOR XR 53 ezetimibe Zetia 53 FOSRENOL R 53 stent thrombosis 53 systemic embolism 53 perioperative morbidity 53 serum phosphate 53 fasting plasma glucose 53 serum triglycerides 53 coinfected patients 53 EGFR mutations 53 NYHA class 53 intracerebral haemorrhage 53 dietary intake 53 mitochondrial toxicity 53 screening colonoscopies 53 oral anticoagulant 53 dysglycemia 53 Betaferon ® 53 calcium intake 53 antibiotic therapy 53 vascular inflammation 53 CsA 53 herpes zoster vaccine 53 GnRH agonist 53 mildly symptomatic 53 desvenlafaxine succinate 53 homocysteine lowering 53 adjuvant radiotherapy 53 pramlintide 53 heart disease 53 atypical antipsychotic drugs 53 anti hypertensive 53 Cypher Stent 53 disease CHD 53 skin sterol 53 acute myocardial infarction 53 NSTEMI 53 renoprotective 53 stimulant medications